"De-liver-ance" from CB 1 : A way to counteract insulin resistance?

Gastroenterology

Volumn 142, Issue 5, 2012, Pages 1063-1066

  Di Marzo, Vincenzo ^a  

^a CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANANDAMIDE; CANNABINOID 1 RECEPTOR;

ENDOPLASMIC RETICULUM STRESS; FOOD INTAKE; GENOTYPE; GLUCONEOGENESIS; GLUCOSE INFUSION; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLYCOGENOLYSIS; HYPERINSULINEMIA; INSULIN CLEARANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; WEIGHT GAIN;

EID: 84860170410     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2012.03.011     Document Type: Editorial

References (20)

1. I. Matias, M.P. Gonthier, P. Orlando Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia J Clin Endocrinol Metab 91 2006 3171 3180
2. K. Eckardt, H. Sell, A. Taube Cannabinoid type 1 receptors in human skeletal muscle cells participate in the negative crosstalk between fat and muscle Diabetologia 52 2009 664 674
3. F.J. Bermudez-Silva, J. Suarez, E. Baixeras Presence of functional cannabinoid receptors in human endocrine pancreas Diabetologia 51 2008 476 487
4. D. Osei-Hyiaman, J. Liu, L. Zhou Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice J Clin Invest 118 2008 3160 3169
5. V. Di Marzo, J.P. Despres CB1 antagonists for obesity-what lessons have we learned from rimonabant? Nat Rev Endocrinol 5 2009 633 638
6. J. Liu, L. Zhou, K. Xiong Hepatic cannabinoid receptor-1 mediates diet-induced insulin resistance via inhibition of insulin signaling and clearance in mice Gastroenterology 142 2012 1218 1228
7. F.J. Bermudez-Silva, A. Serrano, F.J. Diaz-Molina, Liu Activation of cannabinoid CB1 receptors induces glucose intolerance in rats Eur J Pharmacol 531 2006 282 284
8. C. Quarta, L. Bellocchio, G. Mancini CB(1) signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance Cell Metab 11 2010 273 285
9. Z. Pang, N.N. Wu, W. Zhao The central cannabinoid CB1 receptor is required for diet-induced obesity and rimonabant's antiobesity effects in mice Obesity (Silver Spring) 19 2011 1923 1934
10. J.D. O'Hare, E. Zielinski, B. Cheng Central endocannabinoid signaling regulates hepatic glucose production and systemic lipolysis Diabetes 60 2011 1055 1062
11. R. Nogueiras, C. Veyrat-Durebex, P.M. Suchanek Peripheral, but not central, CB1 antagonism provides food intake-independent metabolic benefits in diet-induced obese rats Diabetes 57 2008 2977 2991
12. G. Mancini, C. Quarta, R.K. Srivastava Adipocyte-specific CB1 conditional knock-out mice: new insights in the study of obesity and metabolic syndrome 2010 20th Annual Symposium of the International Cannabinoid Research Society Lund, Sweden
13. T. Watanabe, N. Kubota, M. Ohsugi Rimonabant ameliorates insulin resistance via both adiponectin-dependent and adiponectin-independent pathways J Biol Chem 284 2009 1803 1812
14. S. Migrenne, A. Lacombe, A.L. Lefevre Adiponectin is required to mediate rimonabant-induced improvement of insulin sensitivity but not body weight loss in diet-induced obese mice Am J Physiol Regul Integr Comp Physiol 296 2009 R929 R935
15. A. Bartelt, P. Orlando, C. Mele Altered endocannabinoid signalling after a high-fat diet in Apoe (-/-) mice: relevance to adipose tissue inflammation, hepatic steatosis and insulin resistance Diabetologia 54 2011 2900 2910
16. K.M. Starowicz, L. Cristino, I. Matias Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet Obesity (Silver Spring) 16 2008 553 565
17. W. Kim, M.E. Doyle, Z. Liu Cannabinoids inhibit insulin receptor signaling in pancreatic beta-cells Diabetes 60 2011 1198 1209
18. D. Song, R.H. Bandsma, C. Xiao Acute cannabinoid receptor type 1 (CB1R) modulation influences insulin sensitivity by an effect outside the central nervous system in mice Diabetologia 54 2011 1181 1189
19. R. Murumalla, K. Bencharif, L. Gence Effect of the cannabinoid receptor-1 antagonist SR141716A on human adipocyte inflammatory profile and differentiation J Inflamm (Lond) 8 2011 33
20. C. Pagano, C. Pilon, A. Calcagno The endogenous cannabinoid system stimulates glucose uptake in human fat cells via phosphatidylinositol 3-kinase and calcium-dependent mechanisms J Clin Endocrinol Metab 92 2007 4810 4819